Clinical trial
Evaluation of an asPirin-free Strategy With ticAgrelor in patieNTs witH a Myocardial Infarction treatEd Medically alONe (PANTHEON)
NCT07257198 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of an asPirin-free Strategy With ticAgrelor in patieNTs witH a Myocardial Infarction treatEd Medically alONe (PANTHEON)
- Lead sponsor
- Montreal Heart Institute
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- March 3, 2026
- Completion date
- January 1, 2031
- Enrollment
- 2,570 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
myocardial infarction, nstemi - non-st segment elevation mi, stemi (st elevation mi)